Login
- Titel:
A phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle invasive bladder cancer (NMIBC): CheckMate 9UT.
- Dokumenttyp:
- Meeting Abstract
- Autor(en):
- Hahn, Noah M.; Chang, Sam; Meng, Maxwell; Shore, Neal D.; Konety, Badrinath R.; Steinberg, Gary D.; Gschwend, Juergen; Nishiyama, Hiroyuki; Palou, Joan; Taylor, John A.; Lambert, Alexandre; Zhu, Li; Maeda, Toshiki; Raybold, Bradley; Fischer, Bruce S.; Jeyamohan, Chandrika; Zardavas, Dimitrios; Witjes, Fred
- Zeitschriftentitel:
- J Clin Oncol
- Jahr:
- 2020
- Band / Volume:
- 38 Suppl S
- Heft / Issue:
- 15
- Print-ISSN:
- 0732-183X
- TUM Einrichtung:
- Urologische Klinik und Poliklinik
BibTeX